VANESSA SCHLAUDERAFF: Open Payments
NPI 1336685080 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 27 payments from 7 companies in 2025. Trend: 2023 $164 · 2024 $146 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $224 |
| Braeburn Inc. | 7 | $142 |
| Janssen Pharmaceuticals, Inc | 5 | $125 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Abbott Laboratories | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: SUBLOCADE, BRIXADI, INVEGA SUSTENNA, AUSTEDO XR, ETERNA, UZEDY, ABILIFY ASIMTUFII, PROCLAIM.
Industry payments across AZ — which companies pay providers there.
